A prospective, open-label, interventional, non-comparative, multi-centric active post-marketing surveillance to evaluate the efficacy and safety of Magics hair powder in subjects with male-pattern hair loss - NI

DN Global0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1.Healthy male subjects in the age range of 18 to 50 years
•2.Subjects which are not bald ?, and have type I to type III male-pattern hair loss according to Hamilton classification
•3.Subjects willing to give written informed consent
•4.Subjects agreed not to use any medication, including vitamins and minerals, or any cosmetic products during the course of this study, which are designed to impact hair health

•1.Subjects with a history of allergic or sensitivity reactions to any cosmetic products
•2.Subject with known hypersensitivity to any specific ingredients of investigational product
•3.Subjects previously undergone hair transplantation procedures
•4.Subjects with skin diseases
•5.Subjects being treated for hair fall or severe active infection of any type
•6.Subject with underlying significant uncontrolled medical illness such as cardiovascular, respiratory, renal, gastrointestinal, hepatic, immunologic, hematological, endocrine, or nervous systems or psychiatric disease
•7.HIV positive subjects
•8.Subjects with pre-existing scalp disorder such as scalp psoriasis, lichen planus, lichen planopilaris, discoid lupus erythematosus, sebopsoriasis except dandruff
•9.Subjects participated in a clinical trial within 30 days prior to screening
•10.Any other health or mental condition that in the Investigator’s opinion may adversely affect the ability to complete the study or its measures or that may pose significant risk to the subject

发起方

DN Global